Use of botulinum neurotoxin in the treatment of piriformis syndrome

doi:10.1017/CBO9781139178068.031

Chapter 30 - Use of botulinum neurotoxin in the treatment of piriformis syndrome

Published online by Cambridge University Press: 05 February 2014

Loren M. Fishman and

Edited by

Mark Hallett and

Loren M. Fishman: Affiliation:
Department of Rehabilitation and Regenerative Medicine, Columbia College of Physicians and Surgeons, New York, USA
Sarah B. Schmidhofer: Affiliation:
Department of Psychiatry, Warren Alpert Medical School, Brown University, Providence, RI, USA
Daniel Truong: Affiliation:
The Parkinson’s and Movement Disorders Institute, Fountain Valley, California
Dirk Dressler: Affiliation:
Department of Neurology, Hannover University Medical School
Mark Hallett: Affiliation:
George Washington University School of Medicine and Health Sciences, Washington, DC
Christopher Zachary: Affiliation:
Department of Dermatology, University of California, Irvine

Book contents

Get access

Summary

Introduction

Piriformis syndrome is entrapment of the sciatic nerve by the piriformis muscle, causing sciatica. One estimate puts the incidence of sciatica of non-disc origin as equal to or greater than that of herniated disc, based on comparison of the number of lumbar MRI scans versus the number of subsequent surgery for lumbar disc problems in 239 subjects in 2002 (Filler et al., 2005). The same study found intensive MRI evidence that piriformis syndrome accounted for a full 67% of sciatica of non-disc origin. Regardless of exact incidence, it seems fair to say that sciatica of non-disc origin is common and that in some circumstances the diagnosis of piriformis syndrome is controversial. Some investigators (Halpin and Ganju, 2009; Miller et al., 2012) find the syndrome undefined and infrequent.

In the 25-year period from 1987 to 2012, our own experience has included over 17 000 patients referred or self-referred for piriformis syndrome, approximately half of whom ultimately had the diagnosis confirmed. Since we are a referral center for the condition, our data cannot be used as a suitable sample from which to derive incidence or prevalence figures. However, the average length of time that our patients have had the pain related to piriformis syndrome has fallen from 6.5 years (Fishman et al., 2002a,b) to well below 2 years, suggesting, at least, that the syndrome is being recognized and treated more quickly than in the past, and that although recognized incidence is rising, prevalence is declining.

Information

Type: Chapter
Information: Manual of Botulinum Toxin Therapy , pp. 259 - 268

DOI: https://doi.org/10.1017/CBO9781139178068.031 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2014

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Beaton, LE, Anson, BJ (1937). Relation of sciatic nerve and subdivisions to piriformis muscle. Anat Rec, 70(Suppl 1), 1–3.CrossRef Google Scholar

Benzon, HT, Katz, JA, Hubert, A, Benzon, BA, Iqbal, MS (2003). Piriformis syndrome: anatomic considerations, a new injection technique, and a review of the literature. Anaesthesiology, 98, 1442–8.CrossRef Google Scholar

Childers, MK, Wilson, DJ, Gnatz, SM, Conway, RR, Sherman, AK (2002). Botulinum toxin type A use in piriformis muscle syndrome: a pilot study. Am J Phys Med Rehabil, 81, 751–9.CrossRef Google Scholar PubMed

Filler, AG, Haynes, J, Jordan, SE et al. (2005). Sciatica of nondisc origin and piriformis syndrome:diagnosis by magnetic resonance neurography and interventional magnetic resonance imaging with outcome study of resulting treatment. J Neurosurg Spine, 2, 99–115.CrossRef Google Scholar PubMed

Fishman, LM, Ardman, CA (1997). Back Talk, How to Diagnose and Cure Low Back Pain and Sciatica. New York: Norton.Google Scholar

Fishman, LM, Zybert, PA (1992). Electrophysiological evidence of piriformis syndrome. Arch Phys Med Rehabil, 73, 359–64.CrossRef Google Scholar

Fishman, LM, Dombi, GW, Michaelsen, C et al. (2002a). Piriformis syndrome: diagnosis, treatment and outcome- a ten year study. Arch Phys Rehabil, 83, 295–302.CrossRef Google Scholar

Fishman, LM, Anderson, C, Rosner, B (2002b).Botox and physical therapy in the treatment of piriformis syndrome. Am J Phys Med Rehabil, 81, 936–42.CrossRef Google Scholar PubMed

Fishman, LM, Konnoth, C, Rozner, B (2004). Botulinum neurotoxin type B and physical therapy in the treatment of piriformis syndrome: a dose-finding study. Am J Phys Med Rehabil, 83, 42–50.CrossRef Google Scholar PubMed

Fishman, SM, Caneris, OA, Bandman, TB, Audette, JF, Borsook, D (1998). Injection of the piriformis muscle by fluoroscopic and electromyographic guidance. Reg Anesth Pain Med, 23, 554–9.Google Scholar PubMed

Freiberg, AH (1937). Sciatic pain and its relief by operations on muscle and fascia. Arch Surg, 34, 337–50.CrossRef Google Scholar

Gotlin, R (1990). Piriformis muscle syndrome. In Proceedings of the New York Academy of Medicine Section on Physical Medicine and Rehabilitation, May.

Halpin, RJ, Ganju, A (2009). Piriformis syndrome: a real pain in the buttock?Neurosurgery, 65(Suppl), A197–202.CrossRef Google Scholar PubMed

Hanania, M (1997). New technique for piriformis muscle injection using a nerve stimulator. Reg Anesth Pain Med, 22, 200–2.CrossRef Google Scholar PubMed

Hanania, M, Kitain, E (1998). Perisciatic injection of steroid for the treatment of sciatica due to piriformis syndrome. Reg Anesth Pain Med, 23, 223–8.Google Scholar PubMed

Jensen, MC, Brant-Zawadziki, MN, Obuchowski, N et al. (1994). Magnetic resonance imaging of the lumbar spine in people without back pain. N Engl J Med, 331, 69–73.CrossRef Google Scholar PubMed

Kirschner, JS, Foye, PM, Cole, JL (2009). Piriformis syndrome, diagnosis and treatment. Muscle Nerve, 40, 10–18.CrossRef Google Scholar PubMed

Lang, AM (2004). Botulinum toxin type B in piriformis syndrome. Am J Phys Med Rehabil, 83, 198–202.CrossRef Google Scholar PubMed

Lockhart, RD, Hamilton, GF, Fyfe, FW (1959). Anatomy of the Human Body. Philadelphia, PA: Lippincott.Google Scholar

Martin, HD, Shears, SA, Johnson, JC, Smathers, AM, Palmer, IJ (2011). The endoscopic treatment of sciatic nerve entrapment/deep gluteal syndrome. Arthroscopy, 27, 172–81.CrossRef Google Scholar PubMed

Masala, S, Crusco, S, Meschini, A et al. (2012). Piriformis syndrome: long term follow-up in patients treated with percutaneous injection of anaesthetic and corticosteroid under CT guidance.Cardiovasc Intervent Radiol, 35, 375–82.CrossRef Google Scholar PubMed

Miller, TA, White, KP, Ross, DC (2012). The diagnosis and management of Piriformis syndrome: myths and facts. Can J Neurol Sci, 39, 577–83.CrossRef Google Scholar PubMed

Mizuguchi, T (1976). Division of piriformis muscle for the treatment of sciatica. Arch Surg, 111, 719–22.CrossRef Google Scholar

Ogeng’o, JA, El-Busaidy, H, Mwika, PM, Khanbhai, MM, Munguti, J (2011). Variant anatomy of sciatic nerve in a black Kenyan population. Folia Morphol, 70, 175–9.Google Scholar

Pace, JB, Nagle, D (1976). Piriform syndrome. West J Med, 124, 435–9.Google Scholar PubMed

Pećina, M (1979). Contribution to the etiological explanation of the piriformis syndrome. Acta Anat (Basel), 105: 181–7.Google Scholar PubMed

Pećina, HI, Boric, I, Smoljanovic, T, Duvancic, D, Pecina, M (2008). Surgical evaluation of magnetic resonance imaging findings in piriformis muscle syndrome. Skel Radiol, 37, 1019–23.CrossRef Google Scholar PubMed

Porta, M (2000). A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm. Pain 85, 101–5.CrossRef Google Scholar PubMed

Sharma, T, Singla, RK, Lalit, M (2010). Bilateral eventration of sciatic nerve. J Nepal Med Assoc, 50, 309–12.Google Scholar PubMed

Solheim, LF, Siewers, P, Paus, B (1981). The piriformis muscle syndrome. J Orthop Scand, 52, 73–5.CrossRef Google Scholar PubMed

Sridhara, CR, Izzo, KL (1985). Peroneal nerve entrapment syndrome. Arch Phys Med Rehabil, 66, 789–91.Google Scholar

Sunderland, S (1868). Nerves and Nerve Injuries. Baltimore, MD: Williams & Wilkins.Google Scholar

US Pharmacopeial Convention (2012). United States Pharmacopeia. Rockville, MD: US Pharmacopeial Convention.Google Scholar

Waseem, Z, Boulias, C, Gordon, A et al. (2011). Botulinum toxin injections for low-back pain and sciatica. Cochrane Database Syst Rev, (1), CD008257.Google Scholar

Accessibility standard: Unknown

Accessibility compliance for the PDF of this book is currently unknown and may be updated in the future.